Vimarsana
Biggest News Aggregation in the World

Page 5 - Care Tests News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Care Tests. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Care Tests Today - Breaking & Trending Today

PromarkerD significantly outperforms current standard of care tests in predicting future kidney function decline - Vimarsana News

PromarkerD significantly outperforms current standard of care tests in predicting future kidney function decline

Study shows PromarkerD is significantly better than current standard of care tests eGFR and ACR for predicting future decline in kidney function in patients...

PromarkerD significantly outperforms current standard of care tests in predicting future kidney function decline - Vimarsana News

PromarkerD significantly outperforms current standard of care tests in predicting future kidney function decline

Study shows PromarkerD is significantly better than current standard of care tests eGFR and ACR for predicting future decline in...

Global Molecular Diagnostics for Infectious Disease Market 2021-2025: New Genotypes Creating New Markets / Aging Population a Boon for All Diagnostics / Developing World Driving ID Dx Growth - Vimarsana News

Global Molecular Diagnostics for Infectious Disease Market 2021-2025: New Genotypes Creating New Markets / Aging Population a Boon for All Diagnostics / Developing World Driving ID Dx Growth

8.2.3 Wellness Hurts 8.3 Instrumentation and Automation 8.3.2 The Shrinking Machine 8.4 Diagnostic Technology Development 8.4.2 POCT/Self Testing as a Disruptive Force 8.4.3 The Genetics Play - One Test for All Known Infections 8.4.4 Antibiotic Resistance Genes - Simplifying Diagnostics 9 Molecular Dx - Infectious Disease Recent Developments 9.1 Recent Developments - Importance and How to Use This Section 9.1.1 Importance of These Developments 9.1.2 How to Use This Section 9.2 Roche to Acquire GenMark Diagnostics for $1.8B 9.3 Lucira Health Focuses on User Friendly Approach to Home Testing 9....

Northwestern spinoff receives $21.3M from NIH to manufacture COVID-19 test - Vimarsana News

Northwestern spinoff receives $21.3M from NIH to manufacture COVID-19 test

Northwestern spinoff receives $21.3M from NIH to manufacture COVID-19 test Highly sensitive PCR test takes 15 minutes, using cereal box-sized device A user inserts a small cartridge, holding a nasal swab sample, into a DASH system. A new, highly sensitive, easy-to-use test for COVID-19 that requires a single swab and 15 minutes has received $21.3 million from the National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADx SM) initiative. Developed at Northwestern University’s Center for Innovation in Global Health Technologies (CIGHT), the point-of-care technology is being...

Worldwide OTC/DTC Infectious Disease Diagnostics Industry to 2025 - Privacy and Anonymity is Driving Growth - Vimarsana News

Worldwide OTC/DTC Infectious Disease Diagnostics Industry to 2025 - Privacy and Anonymity is Driving Growth

4.2.3 Wellness Hurts 4.3 Diagnostic Technology Development1 4.3.2 NAT vs. Lateral Flow 4.3.3 The Unusual Role of GPS 4.3.4 Self and Send Competition 4.4.5 The Relationship to DTC Genetic 4.4.6 The Relationship to TeleHealth 4.4.7 Sample Collection - Who Knew? 5. OTC/DTC Infectious Disease Testing Recent Developments Recent Developments - Importance and How to Use This Section Importance of These Developments FDA Grants EUAs for Direct-to-Consumer Coronavirus Kit Stanford Developing Low-Cost, At-Home, COVID-19 Saliva Test Lucira Health Files for $115M IPO Spectrum Solutions Gets CE Mark ...